Quantitative computed tomography software has huge potential to develop imaging biomarkers to improve the management of fibrosing interstitial lung diseases, but optimising their adoption will require technical and societal challenges to be addressed.
Read the pick of the week | Submit your manuscript to the European Respiratory Review
Friday, 12 April 2024
ERR pick of the week
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment